专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

EP3299026B1 EXTRAKTE AUS SAMEN VON AFRAMOMUM-ARTEN UND DEREN VERWENDUNG 有权转让
公开(公告)号：EP3299026B1
公开(公告)日：2020-05-27
申请号：EP16190132.7
申请日：2016-09-22
申请人： Dr. Willmar Schwabe GmbH & Co. KG
发明人： KOCH, Egon , VOGEL, Susanne
IPC分类号： A61K36/906 , A61K8/04 , A61P17/00 , A61K8/9794 , A61Q19/00

2. 发明公开

EP3589372A2 CHEMOTHERAPEUTIC DRUG COMPOSITION 审中-公开
公开(公告)号：EP3589372A2
公开(公告)日：2020-01-08
申请号：EP18855220.2
申请日：2018-03-01
申请人： Yeditepe Universitesi
发明人： TELCI, Dilek , NAYMAN, Ayse Hande
IPC分类号： A61P35/00 , A61K36/00 , A61K9/00 , A61K45/06 , A61K36/899 , A61P17/02 , A61K36/8962 , A61K36/906

3. 发明授权

EP2572710B1 NOVEL USE OF PANDURATIN DERIVATIVES OR AN EXTRACT OF BOESENBERGIA PANDURATA FOR PROMOTING MUSCLE MASS GROWTH, FIGHTING FATIGUE, AND ENHANCING EXERCISE PERFORMANCE CAPABILITY 有权转让
标题翻译：新的泛酸衍生物或硼砂提取物用于促进肌肉增长，减缓疲劳，提高运动能力
公开(公告)号：EP2572710B1
公开(公告)日：2018-04-11
申请号：EP11783791.4
申请日：2011-05-20
申请人： Biocare Co., Ltd. , NEWTREE CO., LTD.
发明人： HWANG, Jae-Kwan , KIM, Do Un
IPC分类号： A61P43/00 , A61P21/00 , A61K31/05 , A61K36/906
CPC分类号： A61K36/906 , A23L33/105 , A61K31/12 , A61K36/00
摘要： The present invention relates to the novel use of panduratin derivatives or an extract of Boesenbergia pandurata for enhancing muscle mass growth, fighting fatigue and enhancing exercise performance, and more particularly to a composition for promoting an increase in muscles, anti-fatigue composition and a composition for enhancing muscle mass growth and recovery from fatigue to improve exercise performance, the composition comprising a panduratin derivative or a salt thereof or an extract of Boesenbergia pandurata as an active ingredient, and to a method for enhancing muscle mass growth, of treating or preventing fatigue syndrome and enhancing exercise performance, the method comprising a panduratin derivative or a salt thereof or a extract of Boesenbergia pandurata to a subject in need thereof. A panduratin derivative or a salt thereof or an extract of Boesenbergia pandurata of the present invention may be used without side effect and has the effect of increasing the expression of PPAR-´ in muscles to increase muscle mass, promoting recovery from fatigue and increase mobility, thereby improving exercise performance.

4. 发明公开

EP3295794A1 METHODS AND COMPOSITIONS FOR PREVENTING AND RELIEVING MUSCLE CRAMPS AND FOR RECOVERY FROM NEUROMUSCULAR IRRITABILITY AND FATIGUE FOLLOWING EXERCISE 审中-公开
公开(公告)号：EP3295794A1
公开(公告)日：2018-03-21
申请号：EP17185391.4
申请日：2011-07-27
申请人： Flex Pharma, Inc.
发明人： BEAN, Bruce P. , MACKINNON, Donald , MACKINNON, Roderick
IPC分类号： A01N37/18 , A61K31/16 , A61P21/00 , A61K31/12 , A61K31/375 , A61K31/165 , A61K36/81 , A61K36/906 , A61K36/54 , A61K9/06 , A61K9/08 , A61K33/42 , A23L2/52 , A61K9/00 , A61K36/9068 , A61K31/19
CPC分类号： A61K31/165 , A23L2/52 , A23V2002/00 , A61K9/0053 , A61K9/0095 , A61K9/06 , A61K9/08 , A61K31/12 , A61K31/16 , A61K31/19 , A61K31/194 , A61K31/375 , A61K33/42 , A61K36/54 , A61K36/81 , A61K36/906 , A61K36/9068 , A61K2300/00
摘要： The methods and compositions of the present invention are directed to the treatment or amelioration of muscle cramps using a composition that includes one or more TRPV1 channel activators, and/or one or more TRPA1 channel activators, and/or one or more ASIC channel activators.

5. 发明授权

EP2353605B1 Use of overground part of hedychium coronarium koenig in reducing blood glucose; extracts and compositions of overground part of hedychium coronarium koenig and their uses 有权转让
标题翻译：姜花的使用科尼格冠的血糖的减少，从姜花和组合物及其用途柯尼希提取
公开(公告)号：EP2353605B1
公开(公告)日：2016-08-24
申请号：EP11152373.4
申请日：2011-01-27
申请人： Development Center for Biotechnology
发明人： Rey-Yuh, Wu , Yu-Yuan, Wu , Lung-Yu, Kuan , Klim, King
IPC分类号： A61K36/906 , A61P3/10
CPC分类号： A61K36/906

6. 发明公开

EP2953637A1 A COMPOSITION FOR TREATING LEUKEMIA 审中-公开
标题翻译：组合物技术治疗白血病
公开(公告)号：EP2953637A1
公开(公告)日：2015-12-16
申请号：EP14715134.4
申请日：2014-02-05
申请人： Universiti Putra Malaysia
发明人： ABDULLAH, Rasedee Mat , RAHMAN, Heshu Sulaiman , ABDUL, Ahmad Bustamam , CHEE WUN, How , SWEE KEONG, Yeap
IPC分类号： A61K36/9068 , A61P35/02 , A61K36/906
CPC分类号： A61K36/906 , A61K36/9068
摘要： The present invention relates to a composition for treating leukemia. The composition comprises of effective amount of zerumbone and a pharmaceutically acceptable carrier characterized in that the carrier is a nanostructure lipid carrier. The composition is safe for administration in human body and shows enhanced bioavailability. The present invention also relates to a method for preparing the composition.

7. 发明公开

EP2637505A4 COMPOSITIONS AND METHODS FOR TREATING ERECTILE DYSFUNCTION 有权
标题翻译：组合物和方法勃起功能障碍的治疗
公开(公告)号：EP2637505A4
公开(公告)日：2014-04-09
申请号：EP11841157
申请日：2011-10-19
申请人： K L R M LLC
发明人： RAJFER JACOB
IPC分类号： A61K36/906 , A61K31/198 , A61K36/185 , A61K36/575 , A61K36/752 , A61K36/77 , A61K36/9068 , A61P15/10
CPC分类号： A61K36/9068 , A61K31/198 , A61K36/185 , A61K36/575 , A61K36/752 , A61K36/77 , A61K2300/00
摘要： Compositions for treating erectile dysfunction (“ED”), including age related erectile dysfunction (ARED), comprise in a preferred embodiment ginger and an amino acid. Preferably the amino acid is L-arginine and/or L-citrulline. Additionally, the compositions may comprise cortex magnoliae officinalis (CMO) and/or fructus aurantil immaturus (FAI). The compositions of the present inventions are administered in a pharmaceutically effective amount to treat erectile dysfunction. For patients that have noticeable symptoms of ED or for older males, whether or not symptomatic, preferred compositions comprises ginger, L-arginine and/or L-citrulline, CMO, FAI, Paullinia cupana, and Muira puama.

8. 发明公开

EP2626112A1 A plant extract from the genus lindera for lowering intraocular pressure 有权
标题翻译： Pflanzenextrakt der Gattung Lindera zur Senkung des Augeninnendrucks
公开(公告)号：EP2626112A1
公开(公告)日：2013-08-14
申请号：EP13154028.8
申请日：2013-02-05
申请人： Korea Institute of Science and Technology
发明人： Jung, Sang Hoon , Jo, Hyoung , Kim, Chul Young , Choi, Soon Jung , Lee, Eun Ha , Kim, Kyung A
IPC分类号： A61P27/06 , A61K36/906
CPC分类号： A61K36/54 , A23L33/105 , A61K2236/30
摘要： The present disclosure relates to a composition containing an extract of a plant in the genus Lindera, more particularly to a composition for lowering intraocular pressure containing the extract. The composition of the present disclosure is useful since it can control intraocular pressure. Further, the composition of the present disclosure is advantageous in that it has fewer side effects than chemical substances and is environmentally friendly since the extract derived from the natural product is used to control the intraocular pressure. In addition, since the extract contained in the composition of the present disclosure can be obtained from the plants in the genus Lindera which are easily available, it can be usefully used economically and commercially.
摘要翻译：本公开内容涉及含有Lindera属植物提取物的组合物，更具体地说，涉及含有该提取物的眼内压降低的组合物。本公开的组合物是有用的，因为其可以控制眼内压。此外，本公开的组合物的优点在于它具有比化学物质更少的副作用，并且是环境友好的，因为来自天然产物的提取物用于控制眼内压。此外，由于本公开的组合物中包含的提取物可以从容易获得的Lindera属植物中获得，因此可以有效地用于经济上和商业上。

9. 发明公开

EP2349305A4 PHYTOCHEMICAL COMPOSITIONS AND METHODS FOR ACTIVATING AMP-KINASE 审中-公开
标题翻译：对于AMP激酶活化植物化学物质的组合物和方法
公开(公告)号：EP2349305A4
公开(公告)日：2012-08-22
申请号：EP09825326
申请日：2009-11-04
申请人： METAPROTEOMICS LLC
发明人： TRIPP MATTHEW L , BABISH JOHN G , PACIORETTY LINDA M , BLAND JEFFREY S
IPC分类号： A61K36/906 , A61K36/185 , A61K36/22 , A61K36/27 , A61K36/33 , A61K36/35 , A61K36/48 , A61K36/61 , A61K36/71 , A61K36/73 , A61K36/738 , A61K36/82 , A61K36/87 , A61K36/9066 , A61K36/9068 , A61K38/01
CPC分类号： A61K36/9068 , A61K36/185 , A61K36/22 , A61K36/27 , A61K36/33 , A61K36/35 , A61K36/48 , A61K36/61 , A61K36/71 , A61K36/73 , A61K36/738 , A61K36/82 , A61K36/87 , A61K36/9066 , A61K38/018

10. 发明公开

EP2351559A4 NOVEL USE OF PANDURATIN DERIVATIVE OR BOESENBERGIA PANDURATA EXTRACT 有权转让
标题翻译：潘多汀衍生物或提琴形凹唇蓬莪萃取物的新用途
公开(公告)号：EP2351559A4
公开(公告)日：2012-03-28
申请号：EP09819415
申请日：2009-10-09
申请人： NEWTREE CO LTD , HWANG JAE KWAN
发明人： HWANG JAE-KWAN , KIM DO UN
IPC分类号： A61K31/05 , A23L1/29 , A61K31/121 , A61K36/906 , A61P3/04 , A61P3/06 , A61P3/10
CPC分类号： A23C9/152 , A23L2/02 , A23L2/52 , A23L13/67 , A23L23/00 , A23L33/105 , A23L33/30 , A61K31/121 , A61K36/906
摘要： The present invention relates to a novel use of a panduratin derivative or a Boesenbergia pandurata extract. More specifically, the invention relates to a composition for preventing and treating/relieving a metabolic disease selected from a group consisting of obesity, hyperlipidemia, hypercholesterolemia and diabetes, containing a panduratin derivative represented by Chemical Formula 1, 2 or 3 or a Boesenbergia pandurata extract as an active ingredient, a method for treating a metabolic disease selected from a group consisting of obesity, hyperlipidemia, hypercholesterolemia and diabetes, by administering an effective amount of the panduratin derivative or the Boesenbergia pandurata extract to a subject in need thereof, and a use of the panduratin derivative or the Boesenbergia pandurata extract to prepare a reagent for preventing and treating/relieving a metabolic disease selected from a group consisting of obesity, hyperlipidemia, hypercholesterolemia and diabetes. As can be seen foregoing, the present invention provides a novel use of a panduratin derivative or a Boesenbergia pandurata extract. A panduratin derivative or a Boesenbergia pandurata extract of the present invention shows excellent effects on a metabolic disease such as obesity, hyperlipidemia, hypercholesterolemia and diabetes by decreasing highly related causes of metabolic diseases such as on weight, body fat and lipid-content. Since a composition of the present invention is originated from natural materials, it can be used without side effect and provides novel method for preventing and treating/relieving a metabolic disease through body weight loss and body fat loss and the like.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式